Rahul Shinde

8PUBLICATIONS
52CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Tumour immunologyPredictive and prognostic markersChemical and thermal processes in energy and combustionImmunogenetics (incl. genetic immunology)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Jun 03, 2026
Chemotherapy induces an IL1β-dependent neutrophil recruitment and activation that promote chemoresistance in metastatic ovarian cancer.

|Nov 03, 2025
Targeting Interactions Between Siglec-10 and α3β1 Integrin Enhances Macrophage-Mediated Phagocytosis of Pancreatic Cancer.

Pratima Saini, Gauri Mirji, S M Shamsul Islam

|Nov 21, 2024
Myeloid activation clears ascites and reveals IL27-dependent regression of metastatic ovarian cancer.

Brennah Murphy, Taito Miyamoto, Bryan S Manning

|Sep 18, 2023
Acetate acts as a metabolic immunomodulator by bolstering T-cell effector function and potentiating antitumor immunity in breast cancer.

Katelyn D Miller, Seamus O'Connor, Katherine A Pniewski

|Jul 13, 2023
The African-centric P47S Variant of TP53 Confers Immune Dysregulation and Impaired Response to Immune Checkpoint Inhibition.

David C Stieg, Joshua L D Parris, Tyler Hong Loong Yang

|Sep 09, 2022
The microbiome-derived metabolite TMAO drives immune activation and boosts responses to immune checkpoint blockade in pancreatic cancer.

Gauri Mirji, Alison Worth, Sajad Ahmad Bhat

Pageof 2

Frequent Collaborators

4 joint publications

Gauri Mirji

2 joint publications

Nan Zhang

2 joint publications

Hsin-Yao Tang

2 joint publications

Mohamed Abdel-Mohsen